Dr. Westerhout oversees the CVC biostatistics and research administration staff, and provides consultation on the design and analysis of clinical studies. She advises the directors, faculty and management team on developing strategic directions for the CVC, and leads strategic planning implementation. Her research interests include novel risk modeling approaches and risk adjustment procedures in acute coronary syndromes and heart failure, and composite endpoints in clinical research. Dr. Westerhout completed a MSc in epidemiology at the University of Alberta in 2001 and a PhD in clinical cardiovascular epidemiology at Erasmus University (Rotterdam, the Netherlands) in 2007. She is currently a member of the editorial board of the American Heart Journal.